Primary Hemostasis During Women's Life Cycle Measured by Thrombostat 4000

Abstract

The Thrombostat 4000 was used to investigate primary hemostasis in women during ditTerent stages of their life cycle. Nonpregnant females were studied during their proliferative and luteal phases; pregnant women were investigated during their 2–35th weeks of gestation and some women between the ages of 70–84. Data were compared to those obtained from male volunteers injected with 40 mg estrogen. No significant ditTerences between proliferative and luteal phases were found, but BT₂ was prolonged in the elderly women. In the pregnant women extremely short BT₂ values were measured. Shortening of BT₂ was also seen in the males injected with estrogen.

Keywords

Thrombostat - estrogen - pregnancy - primary hemostasis - hypercoagulability

• References

• 1 Kratzer MAA, Born GVR. Simulation of primary haemostasis in vitro. Haemostasis 15: 357-362 1985;
• 2 Bonnar J. Coagulation effects of oral contraception. Am J Obstet Gynecol 157: 1042-1048 1987;
• 3 Bremme K, Ostlund E, Almqvist I. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. ObstetGynecol 80: 132-137 1992;
• 4 Suzuki S, Graeff H, Hafter R. Analysis of λ- λ Dimer and Factor XIII during pregnancy and labor. In: Suzuki S, Hathaway WE, Bonnar J, Sutor AH, (eds) Perinatal Thrombosis and Hemostasis . Springer Heidelberg; Berlin: 1991: 21-32
• 5 Suzuki S, Matsuda H, Sakamoto W. The relationship between the onset of labor mechanisms and the blood coagulation system. In: Suzuki S, Hathaway WE, Bonnar J, Sutor AH, (eds) Perinatal Thrombosis and Hemostasis . Springer Heidelberg; Berlin: 1991: 91-102
• 6 Bremme K, Wramsby H, Andersson O, Wallin M, Blombäck M. Do lowered factor VII levels at extremely high endogenous oestradiollevels protect against thrombin formation?. Blood Coag Fibrinolysis 5: 205-210 1993;